BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32343447)

  • 1. Changes of frequency and expression level of CD161 in CD8
    Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
    Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
    Lin YL; Lin SC
    Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
    Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
    Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus.
    Lin SJ; Chen JY; Kuo ML; Hsiao HS; Lee PT; Huang JL
    Mediators Inflamm; 2016; 2016():9675861. PubMed ID: 27847409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
    Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.
    van der Geest KSM; Kroesen BJ; Horst G; Abdulahad WH; Brouwer E; Boots AMH
    Front Immunol; 2018; 9():752. PubMed ID: 29725326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
    Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
    Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
    Hsu CY; Chueh YS; Kuo ML; Lee PT; Hsiao HS; Huang JL; Lin SJ
    PLoS One; 2021; 16(12):e0261727. PubMed ID: 34936686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
    Singleterry WL; Henderson H; Cruse JM
    Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.
    Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW
    J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.
    Rother S; Hundrieser J; Pokoyski C; Kollrich S; Borns K; Blasczyk R; Poehnert D; Klempnauer J; Schwinzer R
    PLoS One; 2015; 10(8):e0135682. PubMed ID: 26309225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
    Comte D; Karampetsou MP; Yoshida N; Kis-Toth K; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2017 May; 69(5):1035-1044. PubMed ID: 28076903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.